PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 93 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $56,000 | -96.0% | 18,200 | -95.7% | 0.00% | -100.0% |
| Q1 2019 | $1,407,000 | -12.8% | 420,130 | -30.7% | 0.00% | -25.0% |
| Q4 2018 | $1,613,000 | -66.8% | 606,295 | -30.1% | 0.00% | -63.6% |
| Q3 2018 | $4,860,000 | -5.8% | 867,855 | -14.7% | 0.01% | -15.4% |
| Q2 2018 | $5,161,000 | -26.5% | 1,017,890 | -1.2% | 0.01% | -18.8% |
| Q1 2018 | $7,023,000 | +108.4% | 1,029,798 | +130.7% | 0.02% | +100.0% |
| Q4 2017 | $3,370,000 | – | 446,371 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |